Abbott Laboratories: One Of The Safest Dividend Growth Stocks On The Market
Abbott Laboratories is a stable investment in challenging times, with an AA- credit rating and a history of surviving economic downturns. ABT has a well-diversified healthcare portfolio, including ...
PETQ vs. ABT: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Products stocks have likely encountered both PetIQ (PETQ) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck...
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.
Ozempic could lead to patients needing to buy fewer interventions for diabetes. It could also do the same for certain cardiovascular interventions.
Abbott rumored to endorse Trump during border visit
Rep. Carlos Gimenez, R-Fla., discusses former President Donald Trump's upcoming trip to Texas on 'The Evening Edit.
Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.
That's the message from many corporate executives who have lately been peppered with questions about how Wegovy, Ozempic and other drugs widely used for weight loss may impact their bottom line.
15 stocks with the closest US government connections
Quiver Quantitative, the pioneering company behind an alternative data platform designed for retail investors, has been actively tracking stock market trades made by US Congress members and other p...
Abbott India's Q2 profit climbs on strong sales
Abbott India , the local unit of U.S. healthcare firm Abbott Laboratories , reported a 17.7% rise in second-quarter profit on Thursday, driven by strong sales in its mainstay pharmaceuticals segment.
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity
The rise of weight-loss treatments has some investors worried about demand for certain medical devices. Yet, DexCom and Abbott Labs still see strong sales for their continuous glucose monitoring de...
3 Dividend Kings to Buy for Royal Returns
Investing in the stock market is a journey of both patience and foresight. Dividend kings reign supreme in this realm, offering high-yield dividends and long-term investment opportunities.
1 Stock Down 15% This Year to Buy and Hold Forever
Abbott Labs' sales have fluctuated in recent years, but its underlying business is solid. Its most important unit should continue performing well despite competitive pressures.
Abbott Labs Vs. Thermo Fisher: Which Is The Better Healthcare Stock?
Thermo Fisher and Abbott are two of our key Healthcare holdings in our fund, and both are among our top 10 holdings overall. Abbott and Thermo Fisher focus on different industries which are Healthc...
FDA issues warning letter to Abbott for probiotic products for infants
The U.S. Food and Drug Administration said on Thursday it has issued a warning letter to Abbott Laboratories for the company's probiotic products sold under the brand Similac Probiotic Tri-Blend fo...
ZBH or ABT: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical - Products sector might want to consider either Zimmer Biomet (ZBH) or Abbott (ABT). But which of these two companies is the best option for those lookin...
5 Stocks to Watch on Solid Revenues in Last Reported Quarter
We have narrowed our search to five U.S. corporate behemoths. These are: JPM, UNH, PG, ABT, FCX.
Are These 3 Dividend Aristocrats Undervalued Hidden Gems?
If you look at MarketBeat's list of dividend aristocrats, you'll see a select group of publicly traded companies that have an outstanding track record of consistently increasing their dividend payo...
Related Companies